We will investigate the co-adaptations of seryl-tRNA synthetase (SerRS), a well
studied class II aminoacyl-tRNA synthetase, with tRNAs through evolution. The
availability of many genomic sequences enables us to clone the genes encoding
SerRS enzymes from the different taxonomic domains. During the previous
NIH-FIRCA grant (supporting the collaboration with Dr. Ivana
Weygand-Durasevic), we focused on identifying the differences in
tRNA:aminoacyl-tRNA synthetase specificities characteristic for the distinct
protein synthesizing compartments of eukaryotic cells (mitochondria and
chloroplasts). Until recently, the study of aminoacyl-tRNA synthesis in archaea
had received little attention. The sequencing of the first archaeal genome
(Methanococcus jannaschii) revealed the "lack" of few canonical aminoacyl-tRNA
synthetases, including the one specific for serine. However, biochemical
analysis of purified and heterologously expressed SerRS-encoding (serS) genes
from two other methanogens, Methanoacterium thermoautotrophicum and
Methanococcus maripaludis, showed that these proteins are SerRS enzymes. Thus,
there are three types of SerRS found in the archaea. The enzyme from the
halophilic archaeon Haloarcula marismortui has high sequence similarity to
bacterial SerRS proteins, while phylogenetic analyses revealed in other archaea
a different clade with sequence similarity to the eukaryotic enzymes. In
contrast, the three methanogenic archaea contain genes that display only low
sequence similarity to the known serS genes from all other organisms and encode
a structurally uncommon enzyme. In the proposed project we will pursue detailed
biochemical, mutational, and structural studies with the aim of elucidating the
structure-function relationships in these unusual seryl-tRNA synthetases. These
studies will complement our ongoing projects on the identification and
characterization of components involved in aminoacyl-tRNA synthesis in the
living kingdom.
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
09-February-2001
Project End Date
31-January-2005
Budget Start Date
01-February-2003
Budget End Date
31-January-2005
Project Funding Information for 2003
Total Funding
$39,020
Direct Costs
$32,000
Indirect Costs
$7,020
Year
Funding IC
FY Total Cost by IC
2003
John E. Fogarty International Center for Advanced Study in the Health Sciences
$39,020
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R03TW001467-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R03TW001467-03
Patents
No Patents information available for 5R03TW001467-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R03TW001467-03
Clinical Studies
No Clinical Studies information available for 5R03TW001467-03
News and More
Related News Releases
No news release information available for 5R03TW001467-03
History
No Historical information available for 5R03TW001467-03
Similar Projects
No Similar Projects information available for 5R03TW001467-03